Monday, 20 September 2021
Dechra® Pharmaceuticals PLC
Annual Financial Report
The Company announced its Preliminary Results on 6 September 2021 in accordance with the financial reporting obligations of the Disclosure and Transparency Rules.
Copies of the Annual Report and Accounts for the year ended 30 June 2021, Notice of Annual General Meeting and Proxy Form have now been mailed to shareholders.
In accordance with Listing Rule 9.6.1 a copy of the Annual Financial Report and Notice of Meeting has been submitted to the FCA document viewing facility https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The Annual Report and Accounts, Notice of Annual General Meeting and information relating to the voting rights of Shareholders (as required by section 311A of the Companies Act 2006) are available to view on the Company's website www.dechra.com. Further copies of the Annual Report and Accounts are available from the Company's registered office at:
24 Cheshire Avenue
Cheshire Business Park
Melanie Hall, Company Secretary
Dechra Pharmaceuticals PLC
Tel: +44 (0) 1606 814730
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
Stock Code: Full Listing (Pharmaceuticals): DPH